This study found that mice with a gain-of-function mutation in the ORAI1 channel pore that results in TAM in humans (Orai1G100S/+ mice) possess multiple hallmarks of the human disease. This evidence concerns the gene ORAI1 and transient myeloproliferative syndrome.